Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
7.93
+0.10 (1.28%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 300 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
300
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$734,537
Profits / Employee
-$75,173
Market Cap
1.14B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
AUPH News
- 1 day ago - Aurinia Pharmaceuticals: There's Still Time For Sales Growth - Seeking Alpha
- 2 days ago - Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025 - Business Wire
- 4 weeks ago - 3 Biotech Stocks With Notable Insider Buying - Seeking Alpha
- 3 months ago - Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis - Business Wire
- 3 months ago - Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024 - Business Wire
- 3 months ago - Aurinia to Participate in Jefferies London Healthcare Conference - Business Wire
- 3 months ago - Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon - Seeking Alpha
- 3 months ago - Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript - Seeking Alpha